Toren Finkel, MD, PhD

Director of the Aging Institute UPMC and the University of Pittsburgh

Toren Finkel, MD, PhD, is one of the world’s most-cited researchers in aging. He joined Pitt and UPMC in 2017 after nearly 25 years at the NIH, where he most recently was chief of the Center for Molecular Medicine at the National Heart, Lung, and Blood Institute. At Pitt, he’s leading an unprecedented basic, translational, and clinical research effort focused on the basic biology of aging, and how to use those insights to alter the trajectory of human aging. He also co-founded Generian, a biotech company created by UPMC to treat diseases commonly associated with aging.

Dr. Finkel earned his undergraduate degree in physics at the University of Maryland and his MD and PhD at Harvard.

Our website uses cookies, including third parties’ profiling cookies, to improve the functionality of the site and your user experience. You can learn more about how we use cookies and how to change your cookies settings in our Privacy Policy. By closing this message, clicking below or continuing to use this site, you consent to our use of cookies.